Chanelle Pharma Named as Pharma Industry Company of the Year 2018

November 2, 2018
Pharmaceutical Technology Editors

Irish manufacturer of generic medicines for both human and animal health, Chanelle Pharma, has been named as Pharma Industry Company of the Year 2018.

Chanelle Pharma, manufacturer of generic medicines for both human and animal health, has been named as Ireland’s Pharma Industry Company of the Year 2018 ahead of multinational companies, such as AbbVie, GE Healthcare, MSD, and Perrigo Company.

The Pharma Industry Awards were founded in 2014 to recognise both individuals and companies demonstrating excellence within the Irish pharma sector. At this year’s event, held in Dublin, Ireland, Chanelle Pharma became the first Irish company to win the overall award and was also the winner of the Pharma Company of the Year (Large) category.

"I am honoured that Chanelle Pharma has been recognised by our peers with this prestigious award. To be named Pharma Industry Company of the Year is a fantastic achievement which reflects on the dedication and commitment of the staff in Chanelle," explained Michael Burke, founder and managing director of Chanelle Pharma in a Nov. 2, 2018 press release. "This Award recognises our growth as a company and our contribution to the Irish economy. It is a tribute to the combined efforts of our people that Chanelle is being recognised in Ireland and worldwide for its manufacturing excellence, its innovation and its exporting success."

Headquartered in Loughrea, Ireland, Chanelle Pharma represents one of the country’s largest exporters and trades with more than 90 countries worldwide. It currently has more than 96 products in its R&D pipeline and is looking to target the United States for future growth.

Source: Chanelle Pharma